Worldwide Clinical Trials

JANUARY 6, 2025

Similarly, the EMAs PRIority MEdicine (PRIME) designation and conditional marketing authorization enable accelerated approval for drugs addressing critical and underserved medical needs, provided they meet stringent evidence requirements.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Genetics 130

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays digital-first world, content marketing campaigns are no longer optional for pharmaceutical brands. Imagine content marketing as the heartbeat of a pharma brands digital presence. But when done right, content marketing campaigns create lasting relationships, drive awareness, and improve patient outcomes.

Branding 52

Branding Marketing Compliance Pharma Companies 52

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference!

Pharmacy 97

Pharmacy Drugs Cardiology Marketing 97

XTalks

APRIL 7, 2022

The LEADLESS II–Phase 2 study was published in the Journal of the American College of Cardiology: Clinical Electrophysiology. According to a report by Persistence Market Research, the market for leadless pacemakers was estimated to be $29.4 The study showed that the implant success was 98 percent and 83.2

FDA Approval 105

FDA Approval Clinical Trials Clinical Trials Cardiology 105

BioTech 365

SEPTEMBER 2, 2020

NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, … Continue reading → SOUTH JORDAN, Utah, Sept.

Radiology 40

Radiology Cardiology Manufacturing Marketing 40

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 97

Drugs Sales Pharma Companies Cardiology 97

pharmaphorum

JUNE 17, 2022

The licensing deal took place as AZ was trimming down its pipeline to focus its R&D activities on the core areas of cardiology, diabetes and neurology, and recovering from a series of patent expiries that hit its revenues. Since then it has bounced back dramatically, thanks to fast-growing drugs for cancer and heart disease.

Licensing 81

Licensing Licensing Cardiology Antibody 81

Velocity Clinical Research

NOVEMBER 21, 2023

“I’m proud and excited to be a part of it.” Dr. Schenkenberger is especially proud of her clinical trial research work in heart health, noting most new drugs never make it to market. The site has 2 full-time investigators and cooperates closely with specialists for internal medicine, orthopedics, neurology, and cardiology.

Medicine 59

Medicine Cardiology Clinical Research Clinical Trials 59

XTalks

JULY 19, 2021

“We successfully brought a medical-grade test, analogs of which are billed by the big players anywhere from $1,500 – $10,000, to a price point more accessible to the consumer market at $249.”. Bisignano added that, “It is time we finally made a medical-grade genetic test available as a proactive, preventative tool.

Genetics 98

Genetics Genome Genomics Gene 98

Velocity Clinical Research

DECEMBER 6, 2023

In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. Gackowska has led international teams dedicated to clinical trials management, product launch, market access, marketing, and sales.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Delveinsight

AUGUST 3, 2021

DelveInsight’s analysis in the report titled, DelveInsight’s Chronic Pain associated with Painful Diabetic Neuropathy – Epidemiology Forecast – 2030 Market Insights, Competitive Landscape and, Market Forecast – 2026 , the market size of the Senza Omnia system is estimated to increase to around USD 3,500 million by 2026.

FDA Approval 98

FDA Approval Marketing Cardiology Production 98

pharmaphorum

JULY 6, 2021

Novartis has tried to get its marketing application for high cholesterol therapy inclisiran in the US back on track, after the FDA rejected it last year, by changing the factory that makes the drug.

RNA 105

RNA Manufacturing Sales Drugs 105

The Pharma Data

JUNE 28, 2021

Food and Drug Administration (FDA) in January 2021 and was recommended for marketing authorization by the Committee for Medicinal Products for Human Use (CHMP) in the EU in May 2021. Additionally, it has been submitted for marketing authorization in China, as well as multiple other countries worldwide. Kenilworth, NJ, USA).

Cardiology 52

Cardiology Production Development Medicine 52

The Pharma Data

DECEMBER 14, 2020

The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the Canadian electrophysiology market. The EPstar catheters are widely used in the Japanese electrophysiology market and were launched in the United States market in 2019.

Cardiology 52

Cardiology Manufacturing Marketing Production 52

pharmaphorum

OCTOBER 2, 2020

They have also been designed to improve the speed and consistency with which commercial research is delivered in the NHS and, by making it easier and quicker to deliver commercial research, the NPRCs will improve the UK’s competitiveness in the global market.

Clinical Trials 92

Clinical Trials Clinical Trials Clinical Research Life Science 92

pharmaphorum

MAY 18, 2021

billion acquisition of Corvidia Therapeutics in June last year, The deal saw the firm begin to explore new markets after making its name in diabetes, a market which is being squeezed by pricing pressures. Data were announced at the virtual American College of Cardiology annual conference and published simultaneously in The Lancet.

Drugs 52

Drugs Cardiology Trials Clinical Trials 52

XTalks

AUGUST 22, 2022

This month, MolecuLight has secured financing from BDC Capital and iGan Ventures to support the company’s global expansion to meet the increasing market demand for their i :X and DX devices. Orthopaedics have X-ray, cardiology has echocardiography, cancer has ultrasound, PET, CT and MRI. Read on to learn more!

Bacteria 111

Bacteria Containment Sales Cardiology 111

Medical Xpress

DECEMBER 21, 2022

Identifying early risks and treatments among children and mothers, continued health disparities and finding new ways to use medications already on the market are among some of the significant scientific research developments in the fight against heart disease and stroke that emerged in 2022.

Research 79

Research Marketing Development Cardiology 79

Delveinsight

JULY 22, 2021

The decision gave Bayer complete control of BlueRock’s cell therapy pipeline, headed by DA01 and spanning various diseases in the neurology , cardiology , and immunology categories. To do so, Omniscient will utilize the financing to expand market access for its existing brain-mapping platforms, in part by increasing its global sales team.

Cardiology 98

Cardiology Development Engineer Clinical Trials 98

pharmaphorum

AUGUST 13, 2020

The cholesterol-lowering drug has been classed as a breakthrough therapy for homozygous familial hypercholesterolaemia (HoFH) by the FDA, which is due to deliver a decision on the marketing application by 11 February after a truncated six-month review.

Drugs 52

Drugs Antibody Sales Cardiology 52

Velocity Clinical Research

MARCH 7, 2024

Currently, he serves on multiple journal editorial boards focusing on Cardiology and Lipidology and has been published in dozens of peer-reviewed publications, books, and abstracts.

Doctors 52

Doctors Doctor Clinical Research Clinical Trials 52

pharmaphorum

JUNE 1, 2021

Novo Nordisk – which is already active in stem cell therapies with a candidate in early development for type 1 diabetes – is on the hook for up to $598 million in total licensing and milestone payments plus royalties on sales if HS-001 reaches the market.

Trials 138

Trials Development Licensing Licensing 138

The Pharma Data

NOVEMBER 2, 2020

market opens on Tuesday, November 17, 2020. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. The Company will host a conference call that day at 8:00 a.m.

Cardiology 40

Cardiology Marketing Development 40

Delveinsight

AUGUST 4, 2020

Billion deal in a thirst to grow in the cancer market. Siemens Healthineers, formed as a result of spin-off in 2018, plans to increase its presence in oncology, neurology as well as cardiology domain. German health group Siemens Healthineers disclosed its plan to acquire Varian Medical Systems in a USD 16.4

Cardiology 55

Cardiology Antibody FDA Approval Trials 55

XTalks

JUNE 11, 2024

Market Dynamics: Understanding Agent DCB’s Competitors Boston Scientific’s Agent DCB operates in an extremely competitive market. This hybrid approach demonstrates the versatility and potential overlap in technology between DES and DCB markets.

Drugs 52

Drugs Drug Delivery Cardiology Marketing 52

ACRP blog

JANUARY 24, 2023

Central to the success of our approach were strategic communications and marketing plans, which enabled us to deliver on ambitious development goals in clinical research,” explains Danielle Eaton, MBA, Director of Clinical Research at Renown Health and University of Nevada, Reno, School of Medicine.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

The Pharma Data

FEBRUARY 21, 2022

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

Radiology 52

Radiology Cardiology Development Production 52

pharmaphorum

DECEMBER 16, 2021

Wellthy enables biopharma & medtech to deploy and scale these solutions, accelerating time to market, while minimising risk and cost. Dr Tunnah holds a BA in Biochemistry and DPhil in Biological Sciences from Oxford University. The post Digital Innovators: Wellthy Therapeutics’ Abhishek Shah appeared first on.

Pharma Companies 40

Pharma Companies Cardiology Life Science Marketing 40

The Pharma Data

OCTOBER 14, 2020

“The global heart failure market represents a tremendous opportunity for Sequana Medical and we look forward to providing an update on the interim results from our RED DESERT study later this year.”. market for the alfa pump resulting from NASH-related cirrhosis is forecast to exceed €3 billion annually within the next 10-20 years.

Cardiology 40

Cardiology Clinical Trials Clinical Trials Medicine 40

The Pharma Data

OCTOBER 15, 2020

15, 2020 — CBD has been widely marketed as a cure-all for whatever ails you, and a new study finds many Americans are buying the sales pitch. The wave of marijuana legalization in the United States has led to a massive surge of CBD products being marketed across the nation, researchers said. THURSDAY, Oct.

Production 52

Production Medicine Doctors Doctor 52

The Pharma Data

JANUARY 26, 2021

Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. The Company’s key product, WatchPAT, is commercially available within major markets including the US, Japan, and Europe.

Cardiology 40

Cardiology Doctors Doctor Marketing 40

pharmaphorum

FEBRUARY 10, 2022

The decision gives Bayer a shot at narrowing the gap with its main rivals in the category – Bristol-Myers Squibb and Johnson & Johnson – which are thought to be out in front the in race to bring an oral FXIa inhibitor to market with their milvexian candidate.

Drugs 98

Drugs Sales Antibody Regulation 98

The Pharma Data

OCTOBER 14, 2020

We are focusing on the pediatric and geriatric market. Recently, the company expanded into prescription drugs with the initial focus on antibiotics and cardiology medications. . Now, we have a large pipeline of gummy drugs in development, from allergy and pain relief medications to fever reducers and cough suppressants.

Drugs 40

Drugs Allergies Cardiology Medicine 40

The Pharma Data

DECEMBER 8, 2020

The company’s commercial priorities are three-fold: (1) Initially focusing its commercial efforts on rare diseases within its prolific neurology and cardiology franchises (2) pioneer new markets where there are no available treatments (3) create new standards of care where there has been a lack of innovation to optimize patient care.

Medicine 52

Medicine RNA Production Marketing 52

pharmaphorum

OCTOBER 2, 2020

They have also been designed to improve the speed and consistency with which commercial research is delivered in the NHS and, by making it easier and quicker to deliver commercial research, the NPRCs will improve the UK’s competitiveness in the global market.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Life Science 52

The Pharma Data

NOVEMBER 2, 2020

market and congratulate all Chiesi team members and partners who supported the clinical process.”. Bronchitol is currently approved and marketed in Australia, Italy, Germany, Russia and several other countries. We’re thrilled to achieve this important milestone for the U.S. Carmen Dell’Anna, Head, Global Medical Excellence at Chiesi.

FDA Approval 52

FDA Approval Bacteria Medicine Cardiology 52

Pharma Marketing Network

JANUARY 12, 2023

During the course of her more than 30 years in the industry, she has spanned a broad range of therapeutic areas, including oncology, immunology, infectious disease, cardiology, neuroscience, Alzheimer’s disease, medical devices, and more.

Life Science 52

Life Science Manufacturing Cardiology Development 52